- Subscribe
- Premium
- C-Suite
- Insiders
- M&A
- Gurus
- Spinoffs
- Buybacks
- More
| Stock | Company | % Portfolio | Shares Held | Market Value | Change in Shares | % Change | Quarter End Price | Source |
|---|---|---|---|---|---|---|---|---|
| PBLS | Parabilis Medicines, Inc. | 4.34% | 26,285,093 | $525,701,860 | 26,285,093 | New | Form 4 | |
| SGP | SPYGLASS PHARMA INC | 1.73% | 8,021,117 | $207,827,141 | 8,021,117 | New | $25.91 | 13F |
| COAG | Hemab Therapeutics Holdings, Inc. | 1.68% | 7,808,628 | $195,059,527 | 7,808,628 | New | Form 4 | |
| ZLAB | ZAI LAB LTD-ADR | 0.89% | 5,707,262 | $107,353,598 | 5,707,262 | New | $18.81 | 13F |
| SRPT | SAREPTA THERAPEUTICS INC | 0.70% | 3,902,596 | $84,920,489 | 3,902,596 | New | $21.76 | 13F |
| IKT | Inhibikase Therapeutics, Inc. | 0.54% | 25,000,000 | $51,000,000 | 25,000,000 | New | 13G | |
| SANA | Sana Biotechnology, Inc. | 0.54% | 18,750,000 | $58,875,000 | 18,750,000 | New | 13G | |
| DMRA | DAMORA THERAPEUTICS INC | 0.52% | 2,399,310 | $62,142,129 | 2,399,310 | New | $25.9 | 13F |
| XNCR | XENCOR INC | 0.49% | 4,897,237 | $59,060,678 | 4,897,237 | New | $12.06 | 13F |
| ALT | Altimmune, Inc. | 0.33% | 13,000,000 | $37,050,000 | 13,000,000 | New | 13G | |
| IPSC | CENTURY THERAPEUTICS INC | 0.33% | 17,754,430 | $40,125,012 | 17,754,430 | New | $2.26 | 13F |
| EDIT | Editas Medicine, Inc. | 0.29% | 8,889,000 | $31,733,730 | 8,889,000 | New | 13G | |
| AGEN | Agenus Inc. | 0.28% | 4,344,772 | $26,590,005 | 4,344,772 | New | 13G | |
| PRLD | Prelude Therapeutics Incorporated | 0.27% | 6,477,309 | $29,925,168 | 6,477,309 | New | 13G | |
| BIOA | BIOAGE LABS INC | 0.24% | 1,650,648 | $28,869,834 | 1,650,648 | New | $17.49 | 13F |
| MIRM | MIRUM PHARMACEUTICALS INC | 0.24% | 318,554 | $29,428,019 | 318,554 | New | $92.38 | 13F |
| ALXO | ALX ONCOLOGY HOLDINGS INC | 0.22% | 13,011,849 | $26,088,757 | 13,011,849 | New | $2 | 13F |
| AKTS | AKTIS ONCOLOGY INC | 0.22% | 1,503,084 | $26,890,173 | 1,503,084 | New | $17.89 | 13F |
| QTTB | Q32 Bio Inc. | 0.22% | 2,332,457 | $24,047,632 | 2,332,457 | New | 13G | |
| ACRS | ACLARIS THERAPEUTICS INC | 0.21% | 6,804,072 | $25,515,270 | 6,804,072 | New | $3.75 | 13F |
| TVTX | TRAVERE THERAPEUTICS INC | 0.18% | 746,841 | $22,188,646 | 746,841 | New | $29.71 | 13F |
| RLMD | RELMADA THERAPEUTICS INC | 0.17% | 2,947,369 | $20,513,688 | 2,947,369 | New | $6.96 | 13F |
| DRUG | BRIGHT MINDS BIOSCIENCES INC | 0.16% | 265,000 | $19,337,050 | 265,000 | New | $72.97 | 13F |
| STRO | SUTRO BIOPHARMA INC | 0.15% | 715,307 | $17,818,297 | 715,307 | New | $24.91 | 13F |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 0.14% | 3,000,000 | $16,650,000 | 3,000,000 | New | $5.55 | 13F |
| OKUR | ONKURE THERAPEUTICS INC-A | 0.14% | 3,998,333 | $16,553,099 | 3,998,333 | New | $4.14 | 13F |
| HLXC | HELIX ACQUISITION CORP-CL A | 0.11% | 1,250,000 | $12,700,000 | 1,250,000 | New | $10.16 | 13F |
| RNA | ATRIUM THERAPEUTICS INC | 0.10% | 864,102 | $11,553,044 | 864,102 | New | $13.37 | 13F |
| KPTI | KARYOPHARM THERAPEUTICS INC | 0.09% | 1,917,354 | $10,679,662 | 1,917,354 | New | $5.57 | 13F |
| CRVS | CORVUS PHARMACEUTICALS INC | 0.05% | 450,000 | $6,583,500 | 450,000 | New | $14.63 | 13F |
| EQ | EQUILLIUM INC | 0.05% | 3,096,336 | $6,192,672 | 3,096,336 | New | $2 | 13F |
| MGNX | MACROGENICS INC | 0.04% | 1,864,176 | $5,387,469 | 1,864,176 | New | $2.89 | 13F |
| MPLT | MAPLIGHT THERAPEUTICS INC | 0.04% | 248,294 | $5,047,817 | 248,294 | New | $20.33 | 13F |
| JATT | JATT II Acquisition Corp | 0.04% | 500,000 | $4,080,000 | 500,000 | New | 13G |